Subsense, Inc. raised $17M in seed funding led by Golden Falcon Capital to develop a non-surgical brain-computer interface using nanoparticle-based technologies.
Subsense, Inc. raised $17M in seed funding led by Golden Falcon Capital to develop a non-surgical brain-computer interface using nanoparticle-based technologies.
02/18/25, 4:20 PM
Location
marina del reyMoney raised
$17 million
Industry
medical device
medical
biotechnology
health care
Round Type
seed
Investors
Golden Falcon Capital
Subsense, Inc. has emerged from stealth with $17M in seed funding to accelerate the development of its innovative brain-computer interface. The funding round was led by Golden Falcon Capital, aiming to enhance neural connectivity through non-invasive methods.
Company Info
Location
marina del rey, california, united states
Additional Info
Subsense, Inc. is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions.
The company is venture-backed with its global headquarters in Palo Alto, California. It is co-founded by neurotech entrepreneur Tetiana Aleksandrova and serial entrepreneur Artem Sokolov, who has been an early investor in companies that include: Asana, SoFi, Coursera, Lemonade, Digital Ocean among many others.